Stockreport

CNS Pharmaceuticals Announces Completion of GMP Manufacturing

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF HOUSTON, Feb. 4, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel [Read more]